RARE SITE OF PLASMOBLASTIC LYMPHOMA IN HIV‑INFECTED PATIENT. FORMATION MECHANISMS, DIAGNOSTICS METHODS
https://doi.org/10.35266/2949-3447-2025-3-10
Abstract
The paper examines and analyzes data obtained by radiological research methods in 15 HIV-infected patients with a histologically verified plasmoblastic lymphoma (PBL) who were treated in the period from 2014 to 2023 in the hematology department of the Surgut District Clinical Hospital. We obtained data that do not contradict the reviews of other researchers. Plasmoblastic lymphoma develops in people aged 40–50 years, malignant lymphoma is commonly first diagnosed at stage III or IV according to the Ann Arbor stages. It is characterized by damage to the oral cavity, but cases of damage to the gastrointestinal tract are not uncommon. This type of lymphoma occurs in 83% of cases in people with severe immunosuppression. In 100% of cases, the association of lymphoma with Epstein–Barr virus (EBV) is revealed.
About the Authors
N. V. Klimova
Surgut State University, Surgut
Russian Federation
Russian Federation
Doctor of Sciences (Medicine), Professor, Head of the Multiprofile Clinic Training Department, Head of the Radiology Department
A. O. Ramzina
Surgut District Clinical Hospital, Surgut
Russian Federation
Russian Federation
Radiologist
References
1. Попова М. О., Цыганков И. В., Гудожникова Я. В. и др. Плазмобластная лимфома у пациентов с ВИЧ-инфекцией: обзор литературы и результаты российского многоцентрового ретро спективного исследования // Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2022. Т. 15, № 1. С. 28–41. https://doi.org/10.21320/2500-2139-2022-15-1-28-41.
2. Swerdlow S. H., Campo E., Pileri S. A. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms // Blood. 2016. Vol. 127, no. 20. P. 2375–2390. https://doi.org/10.1182/blood-2016-01-643569.
3. Li J.-W., Peng H.-L., Zhou X.-Y. et al. Plasmablastic lymphoma: Current knowledge and future directions // Frontiers in Immunology. 2024. Vol. 15. P. 1–8. https://doi.org/10.3389/fimmu. 2024.1354604.
4. Dolcetti R., Gloghini A., Caruso A. et al. A lymphomagenic role for HIV beyond immune suppression? // Blood. 2016. Vol. 127, no. 11. P. 1403–1409. https://doi.org/10.1182/blood-2015-11-681411.
5. Li Y.-J., Li J.-W., Chen K.-L. et al. HIV-negative plasmablastic lymphoma: Report of 8 cases and a comprehensive review of 394 published cases // Blood Research. 2020. Vol. 55, no. 1. P. 49–56. https://doi.org/10.5045/br.2020.55.1.49.
6. Locke F. L., Go W. Y., Neelapu S. S. Development and use of the ANTI-CD19 chimeric antigen receptor T-cell therapy axicabtagene ciloleucel in large B-cell lymphoma // JAMA Oncology. 2020. Vol. 6, no. 2. P. 281–290. https://doi.org/10.1001/jamaoncol.2019.3869.
7. HIV data and statistics. The World Health Organization. HIV data and statistics. URL: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics (дата обращения: 20.09.2024).
8. Zuze T., Painschab M. S., Seguin R. Plasmablastic lymphoma in Malawi // Infectious Agents and Cancer. 2018. Vol. 13. P. 1–4. https://doi.org/10.1186/s13027-018-0195-4.
9. Castillo J. J., Bibas M., Miranda R. N. The biology and treatment of plasmablastic lymphoma // Blood. 2015. Vol. 125, no. 15. P. 2323–2330. https://doi.org/10.1182/blood-2014-10-567479.
10. Han X., Duan M., Hu L. et al. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis // Medicine. 2017. Vol. 96, no. 9. P. 1–5. https://doi.org/10.1097/MD.0000000000005981.
11. Lurain K., Ramaswami R., Mangusan R. et al. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma // Journal for Immunotherapy of Cancer. 2021. Vol. 9, no. 2. P. 1–9. https://doi.org/10.1136/jitc-2020-002097.
12. Pretscher D., Kalisch A., Wilhelm M. et al. Refractory plasmablastic lymphoma – A review of treatment options beyond standard therapy // Annals of Hematology. 2017. Vol. 96. P. 967–970. https://doi.org/10.1007/s00277-016-2904-7.
13. Ahn J. S., Okal R., Vos J. A. et al. Plasmablastic lymphoma versus plasmablastic myeloma: An ongoing diagnostic dilemma // Journal of Clinical Pathology. 2017. Vol. 70, no. 9. P. 775–780. https://doi.org/10.1136/jclinpath-2016-204294.
14. Климова Н. В., Гаус А. А., Рамзина А. О. и др. Три аналогичных случая плазмобластной лимфомы у ВИЧ-инфицированных // ВИЧ-инфекция и иммуносупрессия. 2022. Т. 14, № 2. С. 83–90. https://doi.org/10.22328/2077-9828-2022-14-2-83-90.
Review
For citations:
Klimova N.V., Ramzina A.O. RARE SITE OF PLASMOBLASTIC LYMPHOMA IN HIV‑INFECTED PATIENT. FORMATION MECHANISMS, DIAGNOSTICS METHODS. Vestnik SurGU. Meditsina. 2025;18(3):78–84. (In Russ.) https://doi.org/10.35266/2949-3447-2025-3-10
Views:
11
Email this article 
